Angela Hwang

CEO-Partner and Chief Executive Officer of Metaphore

Angela Hwang joined Flagship Pioneering in 2025 as CEO-Partner and CEO of Metaphore Biotechnologies.

Angela brings nearly three decades of experience at Pfizer where she held various leadership roles, including most recently as a member of Pfizer’s executive leadership team, serving as Chief Commercial Officer and President of the Global Biopharmaceuticals Business. During her tenure, Angela’s teams brought nearly 600 critical therapies in oncology, internal medicine, rare diseases, inflammation and immunology, vaccines and hospital injectables to patients across 185 countries. She has led many groundbreaking product launches during her career, including the world’s first COVID-19 vaccine and oral antiviral treatment, and executed dozens of business development deals to grow and expand Pfizer’s portfolio.

Consistently recognized for her leadership, she has been ranked among the world’s top leaders in healthcare and business. In 2024, Angela was selected by CNBC as a Changemaker in Business. In 2023, she was recognized as a Ascend A-list Honoree for her professional achievements as an Asian American leader. Fortune named her as one of The Most Powerful Women in Business four years in a row from 2020 to 2023. Cornell University named her a Robert S. Hatfield Economic Fellow in 2022. In 2021, she received The President’s Award from the National Diversity Council and was also named an A100 Honoree which recognizes the most impactful AAPI leaders.

Angela is on Cornell’s Johnson Graduate School of Management’s Advisory Committee and is a board member of Connecticut Innovations, Connecticut’s state venture capital fund.

Angela joined the UPS Board of Directors in 2020 and serves on the Audit Committee.

Angela received a Bachelor of Science in Microbiology from the University of Cape Town and an MBA from Cornell University.